Back to results
US 11,884,928 B2Granted
Methods for genetic engineering Kluyveromyces host cells
AssigneeAmyris, Inc.
InventorYoseph Tsegaye
Life of this patent
Estimating the term…
Abstract
The invention provides methods for genetically engineering Kluyveromyces. The methods can be used to genetically engineer Kluyveromyces to produce and secrete full-length antibodies or antibody fragments. The invention also provides methods for production and secretion of antibodies.
Claims5
A method for modifying a target site in a Kluyveromyces host cell genome, the method comprising:
- (a) contacting a Kluyveromyces host cell, which has a reduced non-homologous end joining (NHEJ) activity, wherein the NHEJ activity is reduced by integrating a nucleic acid at YKU70 or YKU80, with:
- (i) a nuclease capable of cleaving the target site;
- and
- (ii) a donor DNA molecule comprising a nucleic acid sequence encoding a polypeptide, wherein the donor DNA molecule is capable of homologous recombination at the cleaved target site, whereby homologous recombination in the host cell results in integration of the donor linear nucleic acid at the target site;
- (b) contacting the host cell with a linear nucleic acid capable of homologous recombination with itself or with one or more additional linear nucleic acids contacted with the host cell, whereby homologous recombination in the host cell converts the linear nucleic acid or the linear nucleic acid and the one or more additional linear nucleic acids into a circular extrachromosomal nucleic acid comprising a coding sequence for a selectable marker;
- and
- (c) selecting a transformed host cell in which the donor DNA molecule is integrated into the target site wherein the host cell secretes the polypeptide encoded by the nucleic acid sequence.
4 more elements
Dependencies are inferred from the claim text.